Formulation and development of floating capsules of celecoxib: in vitro and in vivo evaluation

AAPS PharmSciTech
Javed AliR K Khar

Abstract

The objective of the present study was to develop a hydrodynamically balanced system for celecoxib as single-unit floating capsules. Various grades of low-density polymers were used for formulation of these capsules. The capsules were prepared by physical blending of celecoxib and the polymer in varying ratios. The formulation was optimized on the basis of in vitro buoyancy and in vitro release in citrate phosphate buffer pH 3.0 (with 1% sodium lauryl sulfate). Capsules prepared with polyethylene oxide 60K and Eudragit RL100 gave the best in vitro percentage release and were used as the optimized formulation. By fitting the data into zero-order, first-order, and Higuchi models, we concluded that the release followed zero-order kinetics, as the correlation coefficient (R value) was higher for zero-order release. For gamma scintigraphy studies, celecoxib was radiolabeled with technetium-99m by the stannous reduction method. To achieve the maximum labeling efficiency the process was optimized by studying the reaction at various pH conditions and stannous concentration levels. The radiolabeled complex was added to the optimized capsule, and dissolution studies were performed to ensure that there was no leaching of radioactivity fro...Continue Reading

References

Jan 1, 1992·Journal of Pharmaceutical Sciences·D Harris, J R Robinson
Jul 1, 1991·The Journal of Pharmacy and Pharmacology·P BottenbergD Slop
Jul 1, 1987·Journal of Microencapsulation·M V ShahH Suryakasuma
Apr 1, 1984·Journal of Pharmaceutical Sciences·K D BremeckerG Klein
Jun 1, 1997·Pharmaceutical Research·A A DeshpandeW Malick
Jan 7, 1999·Drug Development and Industrial Pharmacy·G L Chen, W H Hao
Mar 4, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·F KedzierewiczP Maincent
Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·H E JungingerJ C Verhoef
Jun 13, 2001·Drug Delivery·V Pillay, R Fassihi
Dec 6, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·H OkamotoK Danjo
Jan 16, 2002·International Journal of Pharmaceutics·Garnpimol C RitthidejTamotsu Koizumi
Apr 25, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·F O CostaS J Formosinho
Oct 1, 1961·Journal of Pharmaceutical Sciences·T HIGUCHI
Mar 12, 2005·AAPS PharmSciTech·K Gh Desai, T Mp Kumar
Dec 16, 2005·AAPS PharmSciTech·Shweta AroraSanjula Baboota
Aug 1, 1986·Pharmaceutical Research·S S DavisF N Christensen

❮ Previous
Next ❯

Citations

Mar 27, 2012·Expert Opinion on Drug Delivery·Rakesh PahwaKanchan Kohli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Javed AliSanjula Baboota
Methods and Findings in Experimental and Clinical Pharmacology
Javed AliM Ali
© 2021 Meta ULC. All rights reserved